RE-BVS – Piemonte Repository

Sfoglia per AUTORE
VERSINO E
Collezione AOU San Luigi di Orbassano

Items : 12

Moderate Protein Restriction in Advanced CKD: A Feasible Option in An Elderly, High-Comorbidity Population. A Stepwise Multiple-Choice System Approach. in Nutrients / Nutrients. 2018 Dec 24;11(1):36. doi: 10.3390/nu11010036.

2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Versino E; Biolcati M; Capizzi I; Mongilardi E; Froger L; Vigreux J; Kaniassi A; Lippi F; Chatrenet A; Cataldo E; Fois A; Piccoli GB; Fois A; Chatrenet A; Cataldo E; Lippi F; Kaniassi A; Vigreux J; Froger L; Mongilardi E; Capizzi I; Biolcati M; Versino E; Piccoli GB;

Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience. in BMC nephrology / BMC Nephrol. 2016 Sep 20;17(1):132. doi: 10.1186/s12882-016-0339-y.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Minelli F; Alemanno MG; Gerbino M; Maxia S; Rossetti M; Loi V; Colla L; Capizzi I; Parisi S; Fassio F; Leone F; Attini R; Piccoli E; Versino E; Biolcati M; Avagnina P; Pani A; Cabiddu G; Todros T; Piccoli GB;

Inappropriate Proton Pump Inhibitor Prescription in Elderly Adults: As Usual As Dangerous. in Journal of the American Geriatrics Society / J Am Geriatr Soc. 2015 Oct;63(10):2198-9. doi: 10.1111/jgs.13691.

2015
AOU San Luigi di Orbassano

Bergamo D; Pastorino A; Greppi F; Versino E; Bo M; D'Amelio P; Pezzilli MS; Furno E; Isaia G;

Proton pump inhibitors and hypomagnesemia in polymorbid elderly adults. in Journal of the American Geriatrics Society / J Am Geriatr Soc. 2015 Jan;63(1):179-80. doi: 10.1111/jgs.13212.

2015
AOU San Luigi di Orbassano

Pastorino A; Greppi F; Bergamo D; Versino E; Bo M; Pezzilli MS; Furno E; Rrodhe S; Isaia G;

Influence of posterior vitreous detachment and type of intraocular lens on lipid peroxidation in the human vitreous. in Molecular vision / Mol Vis. 2015 Sep 20;21:1106-12. eCollection 2015.

2015
AOU San Luigi di Orbassano

Nuzzi R; Marchese A; Gulino GR; Versino E; Ghigo D;

Which low-protein diet for which CKD patient? An observational, personalized approach. in Nutrition (Burbank, Los Angeles County, Calif.) / Nutrition. 2014 Sep;30(9):992-9. doi: 10.1016/j.nut.2014.01.004. Epub 2014 Jan 25.

2014
AOU San Luigi di Orbassano

Piccoli GB; Deagostini MC; Vigotti FN; Ferraresi M; Moro I; Consiglio V; Scognamiglio S; Mongilardi E; Clari R; Aroasio E; Versino E; Porpiglia F;

Does substance use disorder affect clinical expression in first-hospitalization patients with schizophrenia? Analysis of a prospective cohort. in Psychiatry research / Psychiatry Res. 2013 Dec 30;210(3):780-6. doi: 10.1016/j.psychres.2013.08.043. Epub 2013 Sep 18.

2013
AOU San Luigi di Orbassano

Picci RL; Versino E; Oliva F; Giaretto RM; Ostacoli L; Trivelli F; Venturello S; Furlan PM;

Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2012 May;44(5):406-12. doi: 10.1016/j.dld.2011.12.003. Epub 2012 Jan 14.

2012
AOU San Luigi di Orbassano

Giordanino C; Ceretto S; Bo S; Smedile A; Ciancio A; Bugianesi E; Pellicano R; Fagoonee S; Versino E; Costa G; Arese D; Sacco M; Rizzetto M; Saracco G;

Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose. in Journal of neuroimmunology / J Neuroimmunol. 2010 Sep 14;226(1-2):150-7. doi: 10.1016/j.jneuroim.2010.05.038. Epub 2010 Jun 23.

2010
AOU San Luigi di Orbassano

Cucci A; Barbero P; Clerico M; Ferrero B; Versino E; Contessa G; Demercanti S; Viglietta E; Di Liberto A; Vai AG; Durelli L;

Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2009 Apr;9(4):387-97. doi: 10.1517/14712590902762781.

2009
AOU San Luigi di Orbassano

Durelli L; Barbero P; Cucci A; Ferrero B; Ricci A; Contessa G; De Mercanti S; Ripellino P; Lapuma D; Viglietta E; Bergui M; Versino E; Clerico M;

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders. in Journal of neurology / J Neurol. 2008 Sep;255(9):1315-23. doi: 10.1007/s00415-008-0879-6. Epub 2008 Sep 25.

2008
AOU San Luigi di Orbassano

Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Ferrero B; Rivoiro C; Ferrero C; Picco E; Ripellino P; Viglietti D; Giuliani G; Montanari E; Clerico M;

MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):646-51. doi: 10.1136/jnnp.2007.130229. Epub 2007 Nov 6

2008
AOU San Luigi di Orbassano

Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Rivoiro C; Ferrero C; Picco E; Ripellino P; Giuliani G; Montanari E; Clerico M; Durelli L; Barbero P; Bergui M; Versino E; Bassano MA; Verdun E; Rivoiro C; Ferrero C; Picco E; Ripellino P; Giuliani G; Montanari E; Clerico M;